Ensysce Biosciences, Inc. announced it raised $4.24 Million in an initial filing from an offering of $8.48 Million

Company

Location

About

Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.